MarketBeat
10 May 2026, 09:13 UTC · 21w ago
Verdict
Headline takes no side. We score EVH +0.40 across six claims — moderately bullish.
+0.40moderately bullish
More positive than 66% of ticker scores this week
Scored by the NIS engine · methodology.
What the story claims
6 claims · scored −1 bearish … +1 bullish
A national payer client expanded its oncology and cardiology solution into new markets, expected to generate more than $200 million in annual revenue with a third-quarter launch.
So whatA new contract generating over $200 million in annual revenue represents roughly 8% of the company's full-year guidance midpoint and signals strong organic growth and cross-selling capabilities.
More positive than 99% of claims this week
Specialty Technology and Services revenue fell 16% sequentially due to actual exchange membership losses and required fund returns after disenrollment.
Continue reading
5 related stories
Search tags
More negative than 98% of claims this week
Evolent reaffirmed its full-year 2026 revenue guidance of $2.4B to $2.6B and adjusted EBITDA guidance of $110M to $140M, but maintained caution due to uncertainty around the Highmark launch and exchange membership disenrollment.
More positive than 87% of claims this week
Management expects MER to peak in the third quarter due to reserve building for the Highmark launch and elevated oncology prevalence, before improving in the second half.
So whatA forecasted peak in medical expense ratio signals front-loaded profitability pressure and near-term margin compression before expected operational improvements.
More negative than 86% of claims this week
Which stocks this story touches
More positive than 66% of ticker scores this week
Reported Q1 results in line with expectations, reiterated full-year guidance, and announced significant new contract wins.
More positive than 57% of ticker scores this week
Mentioned as a partner (via Aetna) with a successful January 1 launch and encouraging early clinical indicators.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
31m ago
−3.3%
Price is moving against the score
$4.04 vs $4.18 close before publication (May 8) · not market-adjusted
EVH chart →
